Purinergic (P2X7) receptor activation of microglia induces cell death via an interleukin-1-independent mechanism

被引:115
|
作者
Brough, D [1 ]
Le Feuvre, RA
Iwakura, Y
Rothwell, NJ
机构
[1] Univ Manchester, Sch Biol Sci, Div Neurosci, Manchester M13 9PT, Lancs, England
[2] Univ Tokyo, Inst Med Sci, Lab Anim Res Ctr, Tokyo, Japan
基金
英国生物技术与生命科学研究理事会; 英国医学研究理事会;
关键词
D O I
10.1006/mcne.2001.1054
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Activation of purinergic P2X7 receptors, principally by extracellular ATP, promotes the processing and release of the cytokine interleukin-1beta(IL-1beta) and induces cell death in activated microglia and macrophages. The objective of this study was to determine if IL-1beta release contributes directly to this cell death in microglia. Exposure of microglia to bacterial lipopolysaccharide (LPS) and ATP induced release of IL-1beta and IL-1alpha, as well as cell death. Neither cell death nor IL-1 release was observed in microglia lacking the P2X7 receptor. Microglia from mice lacking the IL-1beta gene demonstrated a profile of death identical to that of wild-type microglia in response to LPS and ATP. Thus, IL-1beta is not required for P2X7 receptor-stimulated microglial death.
引用
收藏
页码:272 / 280
页数:9
相关论文
共 50 条
  • [41] The P2X7 purinergic receptor as a molecular target in bipolar disorder
    Gubert, Carolina
    Fries, Gabriel Rodrigo
    de Aguiar, Bianca Wollenhaupt
    Rosa, Adriane Ribeiro
    Busnello, Joao Vicente
    Ribeiro, Luciana
    Morrone, Fernanda Bueno
    Oliveira Battastini, Ana Maria
    Kapczinski, Flavio
    NEUROPSYCHIATRIA I NEUROPSYCHOLOGIA, 2013, 8 (01): : 1 - 7
  • [42] Purinergic P2X7 Receptor: A Pivotal Role in Surfactant Regulation?
    Mishra, Amarjit
    Chintagari, Narendranath Reddy
    Liu, Lin
    FASEB JOURNAL, 2008, 22
  • [43] Ethanol upregulates the P2X7 purinergic receptor in human macrophages
    Le Dare, Brendan
    Victoni, Tatiana
    Bodin, Aude
    Vlach, Manuel
    Vene, Elise
    Loyer, Pascal
    Lagente, Vincent
    Gicquel, Thomas
    FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2019, 33 (01) : 63 - 74
  • [44] Defiency of Purinergic Receptor P2X7 Reduces Atherosclerosis in Mice
    Stachon, Peter
    Heidenreich, Adrian
    Merz, Julian
    Hoppe, Natalie
    Bode, Christoph
    Idzko, Marco
    Zirlik, Andreas
    CIRCULATION, 2016, 134
  • [45] P2X7 receptor activation leads to increased cell death in a radiosensitive human glioma cell line
    Marina Petersen Gehring
    Talita Carneiro Brandão Pereira
    Rafael Fernandes Zanin
    Magali Carvalho Borges
    Aroldo Braga Filho
    Ana Maria Oliveira Battastini
    Maurício Reis Bogo
    Guido Lenz
    Maria Martha Campos
    Fernanda Bueno Morrone
    Purinergic Signalling, 2012, 8 : 729 - 739
  • [46] Purinergic P2X7 receptor:: A pivotal role in inflammation and immunomodulation
    Di Virgilio, F
    Falzoni, S
    Mutini, C
    Sanz, JM
    Chiozzi, P
    DRUG DEVELOPMENT RESEARCH, 1998, 45 (3-4) : 207 - 213
  • [47] The contribution of monocytes and the purinergic receptor, P2X7, in MS relapse
    Monif, M.
    O'Brien, T.
    Hamilton, J.
    Butzkueven, H.
    MULTIPLE SCLEROSIS JOURNAL, 2018, 24 : 837 - 838
  • [48] Associations Between the Purinergic Receptor P2X7 and Leprosy Disease
    Souza, Rebeka da Conceicao
    de Souza, Thais Louvain
    Ferreira, Cristina dos Santos
    Nascimento, Leticia Silva
    Nahn, Edilbert Pellegrini
    Peixoto-Rangel, Alba Lucinia
    FRONTIERS IN GENETICS, 2021, 12
  • [49] P2X7 receptor activation leads to increased cell death in a radiosensitive human glioma cell line
    Gehring, Marina Petersen
    Brandao Pereira, Talita Carneiro
    Zanin, Rafael Fernandes
    Borges, Magali Carvalho
    Braga Filho, Aroldo
    Oliveira Battastini, Ana Maria
    Bogo, Mauricio Reis
    Lenz, Guido
    Campos, Maria Martha
    Morrone, Fernanda Bueno
    PURINERGIC SIGNALLING, 2012, 8 (04) : 729 - 739
  • [50] The P2X7 purinergic receptor: from physiology to neurological disorders
    Skaper, Stephen D.
    Debetto, Patrizia
    Giusti, Pietro
    FASEB JOURNAL, 2010, 24 (02): : 337 - 345